Insiders · Profile

GAROFALO ELIZABETH A.

Director at ACADIA PHARMACEUTICALS · Director at Xenon Pharmaceuticals. Filing since 8 Mar 2024. CIK 0001826361

Company
Date
Role
Action
Shares
Amount
Of holding
2 Sep 2025
Director
Sold at will
1,600
$41.56K
5.9%
5 Mar 2025
Director
Sold at will
4,919
$89.67K
21.8%
8 Mar 2024
Director
Sold at will
2,092
$95.58K
100%
3 decisions on file.